Related Experiment Videos
[Combined interferon-lamivudine as a first line therapy for chronic hepatitis B]
Gastroenterologie Clinique Et Biologique
|April 9, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Estrogen Receptor Beta (ERβ) Expression in Colorectal Cancer (CRC)-A Systematic Review and Meta-Analysis.
Journal of clinical medicine·2026
Do "Developing" Countries Become "Developed"? Lessons from Helicobacter pylori Infection Recurrence Rate after Eradication.
Digestive diseases (Basel, Switzerland)·2026
Freezing while preserving achievements: suspending quality indicators in healthcare, Israel's experience.
International journal for quality in health care : journal of the International Society for Quality in Health Care·2025
Diagnostic Yield of Video Capsule Endoscopy (VCE) in Celiac Disease (CD): A Systematic Review and Meta-analysis.
Journal of clinical gastroenterology·2025
[Treatment of chronic hepatitis B: adherence and safety].
Gastroenterologie clinique et biologique·2010
[Long-term therapy for chronic hepatitis B in HIV co-infected patients].
Gastroenterologie clinique et biologique·2010
[Analogs combination therapy in chronic hepatitis B: when and how?].
Gastroenterologie clinique et biologique·2010
[HBsAg seroclearance: prognostic value for the response to treatment and the long-term outcome].
Gastroenterologie clinique et biologique·2010
[HBsAg quantification: virological significance].
Gastroenterologie clinique et biologique·2010
[Influence of treatment on long-term evolution of chronic hepatitis B].
Gastroenterologie clinique et biologique·2010
Diagnostic Yield and Cost of Morphology-Guided Immunohistochemistry in Liver Tumors.
Asian Pacific journal of cancer prevention : APJCP·2026
Single-cell transcriptomic profiling of cerebrospinal fluid reveals immune-cell heterogeneity and multicompartment MIF/CD74-related communication in tuberculous and purulent meningitis.
Frontiers in cellular and infection microbiology·2026
Persistent CD8+ T-cell activation (HLA-DR/CD38) as an immunological marker in antiretroviral-treated human immunodeficiency virus-1 patients: A cross-sectional study.
The Journal of international medical research·2026